APPY..$2.70 DD Post. Sheff Holding from $2.35 today. This stock regained nasdaq compliance at $1.95. http://bit.ly/MXBoDl . With a pending near-term catalyst it looks poised to breakout higher.
The company has 10m in cash. They have a book value per share of $1.14. 7m shares O/S and 6m share in the float. A small market cap of only 20m with a closing share price of $2.58. That is very low for a company close to commercialization of their APPY score with a CE Mark.
13% holdings by insiders & 16% holding by institutions. Insider buying by Senior VP Chief Commercial Officer Sept 24th with 15K shares at $1.95. http://1.usa.gov/VAZ3J5
That was 3 months ago. Starting to move here today. A low floater with pending catalyst. They expect their CE Mark at year's end. Company completed their offering on Nov 20th of 1.94m shares at $2.10. http://yhoo.it/T9AOmH
Statement by the CEO from last conf call on Nov 14th..“As we've mentioned previously, we anticipate obtaining CE Mark for our product before the end of the year, and Don is working very hard to make sure that happens, as well as position AspenBio to launch the product successfully in the EU shortly after obtaining CE Mark. As Don will highlight for you, we are making important advancements that we believe will have a significant impact on our commercial success.”
APPY recent Presentation link is below Specific timeline here for this one.
Compare APPY with BGMD which also received a CE mark and two days ago & went from $1.50 per share to $4.48 on 12/12. APPY has a larger book value of $1.14 to .13 and also has a smaller share structure. BGMD is 20m O/S and 17m float. There is a very small short position in both stocks as they are under 4%. That allows for the stock to move.
News 
Market Data 
Discover 
